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Summary
Objectives: To estimate the antibiotic use of individuals visiting public healthcare facilities in
Indonesia and to identify determinants of use against a background of high resistance rates.
Methods: Patients on admission to hospital (group A), visiting a primary health center (group B),
and healthy relatives (group C) were included in the study. A questionnaire on demographic,
socioeconomic, and healthcare-related items including health complaints and consumption of
antibiotics was used. Logistic regression was performed to determine the co-variables of
antibiotic use.
Results: Of 2996 individuals interviewed, 486 (16%) had taken an antibiotic. Compared to group C
(7% consumption), groups B and A exhibited a three-fold and four-fold higher use of antibiotics,
respectively. Respiratory (80%) and gastrointestinal (13%) symptoms were most frequent. Ami-* Corresponding author. Tel.: +62 31 5501617; fax: +62 31 5018434.
E-mail address: i.gyssens@aig.umcn.nl (U. Hadi).
1 on behalf of the Antimicrobial Resistance in Indonesia ‘Prevalence and Prevention’ study group (AMRIN).
1201-9712/$32.00 # 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
doi:10.1016/j.ijid.2008.01.002
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nopenicillins and tetracyclines accounted for 80% of the prescribed antibiotics. Similar antibiotics
were self-medicated (17% of users). Age less than 18 years and health insurance were independent
determinants of antibiotic use. Urban provenance, being adult, male, and having no health
insurance were independent determinants of self-medication.
Conclusions: In addition to health complaints, other factors determined antibiotic consumption.
In view of the likely viral origin of respiratory complaints and the resistance of intestinal
pathogens, most antibiotic use was probably unnecessary or ineffective. Future interventions
should be directed towards healthcare providers.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
Non-industrialized countries, home to the majority of the
world’s population, have an important role in the emergence
of global resistance of bacteria to antimicrobial drugs.1
Antibiotic use contributes to the selection of resistant micro-
organisms.2,3 This problem has become so widespread that
bacterial resistance to antibiotics is threatening health
improvements achieved in the tropics in the past decades.4
Despite the potential impact of this problem, only limited
information on resistance of bacteria and antibiotic con-
sumption is available in Indonesia. Most research has been
done on diarrheal5—8 and sexually transmitted diseases.9
Resistance against penicillins and tetracyclines of diarrheal
pathogens andNeisseria gonorrhoeae has approached 100% in
some areas.8,9 High resistance rates for enterotoxigenic
Escherichia coli have been found against amoxicillin, tri-
methoprim—sulfamethoxazole, chloramphenicol, and tetra-
cycline.7 Ten years ago in a small survey, 70% of patients with
diarrhea and about 80% of patients with respiratory tract
symptoms were treated with antibiotics.10 Doctors in Jakarta
prescribed antibiotics for 94% of young children although
they believed that the infection was usually of viral origin.5
The 1997—1998 East-Asian economic crisis had a major
impact on health and healthcare in Indonesia.11,12 Health
insurance schemes are mandatory for government employees
(Askes, Asuransi Kesehatan) and private employees (Jamsos-
tek, Jaminan Sosial Tenaga Kerja).13 A social safety net
program including health subsidies (JPS, Jaring Pengaman
Sosial) was developed.12 However, up to 86% of the popula-
tion is not covered by any form of health insurance scheme,
and drugs have to be paid for in cash upon delivery.13 Anti-
biotics can be obtained from public and private providers: at
primary health centers, government or private hospitals,
private doctor or midwife practices, public pharmacies,
but also in drug stores and roadside stalls (‘kiosks’).14 In
the health centers a limited number of antibiotics can be
prescribed according to standard practice guidelines for the
treatment of infectious syndromes.15 In public pharmacies,
many generic as well as branded products can be pur-
chased.16 Antibiotics without prescription can be obtained
over the counter (OTC) in pharmacies and drug stores,
although this has been prohibited by law since 1949.17
The Antimicrobial Resistance in Indonesia ‘Prevalence and
Prevention’ (AMRIN) study was set up to investigate antibiotic
resistance and antibiotic use inside and outside hospitals in
two different areas on Java. AMRIN is a two-phased study
whose objective is first to survey the present situation inIndonesia regarding antimicrobial resistance, antibiotic use,
and infection control in healthcare facilities, and next to
perform interventions in those facilities based on the results
of the first phase. We hypothesized that antibiotic use and
carriage of resistant bacteria would differ depending on the
individual’s health and that antibiotic use, and as well as
being driven by morbidity would also be determined by
demographic, socioeconomic, and healthcare-related vari-
ables. Here, we report on the level, diversity, and determi-
nants of antibiotics taken by individuals in the extramural
healthcare setting.
Patients and methods
This study was conducted in Surabaya (SBY) in east Java and
in Semarang (SMG) in central Java. In SBY a governmental
teaching hospital and two urban health centers participated,
in SMG a teaching hospital and one rural health center. The
aim was to include 3000 individuals, equally divided over
three groups. Patients upon admission to hospital in the
departments of Internal Medicine, Surgery, Obstetrics and
Gynecology, or Pediatrics (group A), patients visiting a health
center for consultation or vaccination (group B), and healthy
relatives who accompanied group A patients to hospital
(group C) were eligible.
The medical ethics committees of the hospitals approved
the study protocol (ethical clearance No/Panke.KKE/2001
(Surabaya) and 11/EC/FK/RSDK/2001 (Semarang)). On enrol-
ment, eligible individuals received oral and written informa-
tion about the study, and informed consent was obtained
from all adults and carers of children.
Inclusion procedure and criteria for inclusion and
exclusion
Patients in group A were included within the first 24 hours of
admission. Individuals in group C were included on admission
of group A patients at a rate of one contact per patient.
Contacts had to be able to answer the questions properly and
to be over 12 years old. Patients in group B were included on
specific study days twice weekly in SBY and once weekly in
SMG. Individuals were excluded from the study if they had
been transferred from another hospital, if they were not
accompanied by a relative (group A), or if they had been
admitted to a hospital in the previous three months (groups
A, B, and C).
Demographic and socioeconomic data and data on health
complaints and consumption of antibiotics in the month
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)preceding the study were collected by interviews, performed
by pairs of trained Indonesian and Dutch data collectors
(researchers, residents, medical students). For children
(<17 years), a carer (usually the mother) was interviewed.
Demographic and socioeconomic factors
Origin (SBYor SMG), sex, age, residence (urban or rural), and
ethnicity were recorded. Family income level, employment,
highest educational level, health insurance, and the number
of individuals sharing a household were chosen as socioeco-
nomic characteristics. Employment was defined as paid work
for an employer on a regular basis or having a regular income
from a profession (e.g. farmer). Housewives and students
were not considered as unemployed.
Antibiotic use survey
A semi-structured questionnaire was used. Interviewees
were asked to state their health complaints during the pre-
ceding month spontaneously. Subsequently, the interviewers
cited complaints from the list on the form. Irrespective of
having been ill or not, participants were asked whether they
had consumed any drugs in the past month. If the answer was
no, the interview was ended; otherwise it was continued. To
ascertain whether the drug was an antibiotic, individuals
were asked to show the drugs, the package, or the prescrip-
tions. If these were not available, open questions using the
names of antibiotics were asked or samples of capsules and
tablets of antibiotics were shown. When it was certain that
the drug was an antibiotic, the number of units taken and
duration of treatment were recorded. When in doubt, the
drug was labeled as ‘possibly an antibiotic’. Individuals who
had (possibly) taken an antibiotic were asked where it was
obtained.
Statistical analysis
Individuals with antibiotic use were compared to indivi-
duals without antibiotic use. Proportions were analyzed by
Chi-square testing, using p < 0.05 as the level of signifi-
cance. The mean duration of treatment was assessed by
ANOVA, using p < 0.05 as the level of significance. Uni-
variate analysis was performed to determine the risk
factors for antibiotic use. Employment and education were
analyzed for the population 18 years old. The variables
age (adult versus child <18 years), education (primary
school completed vs. not completed), and family income
(below or above poverty line, <300 000 Rupiah or 30 Euro
per month)12 were analyzed as binary variables. Variables
for which significance at the 0.05 level or higher was found
in univariate analysis were forced into a multivariate
model. Forward stepwise logistic regression was used.
Odds ratios (OR), significance, and 95% confidence inter-
vals (95% CI) were calculated. SPSS for Windows version
11.5 was used for all analyses. The analysis was done for
the outcome ‘antibiotic use’ versus ‘no antibiotic use’ and
repeated for the outcome ‘antibiotic use including possible
use’ versus ‘no antibiotic use’. The analysis was repeated
for the outcome ‘self-medication’ versus ‘prescribed by
healthcare providers’.
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Demography and socioeconomic factors
A total of 3000 individuals were included in this study; 1500
between July and October 2001 in SBY and 1500 between
January and April 2002 in SMG. Four individuals were
excluded, two from group A, together with their relatives
from group C, because these patients had been hospitalized
within the month before inclusion, leaving 2996 individuals
for analysis. The demographic characteristics of the popula-
tion are shown in Table 1. Themajority was female (62%). The
proportions of adults in SBY and SMG were similar, except in
group C ( p < 0.001). In this group, more children were
included from the immunization clinic in SMG. Most indivi-
duals were of Javanese descent; Madurese accounted for 9%
in SBY. This explains the significant difference in ethnicities
between the two areas ( p < 0.001). In SBY, significantly more
individuals were living in an urban area ( p < 0.001), had a
low income ( p < 0.001), and had no health insurance
( p < 0.001) compared to SMG. Overall, three quarters of
the interviewees received no re-imbursement for the costs
of antibiotics. A quarter of the individuals18 years old were
unemployed. About half of the individuals aged 18—40 years
old had completed secondary school. There was a large
variation in the number of individuals belonging to one
household.
Antibiotic consumption
Of the 2996 participants, 1843 (62%) reported that they took
a drug in the month preceding the interview. This was
definitely an antibiotic in 486 cases, 26% of medicine users.
In 262 (14%) cases the interviewee was not sure whether the
drug was an antibiotic. Thus, depending on whether possible
use was taken into account, the antibiotic use of the totalTable 2 Antibiotic use by adults (18 years) in one month
ATC code Group Aa (N = 110)
Courses
n (%)
PDDd Duratione
J01AA07 Tetracycline 12 (11) 1.0 (0.53) 3 (1—7)
J01BA01 Chloramphenicol 5 (4.6) 1.6 (0.51) 2 (1—7)
J01BA02 Thiamphenicol 3 (2.7) 1.5 (0) 3 (2—3)
J01CA01 Ampicillin 20 (19) 1.4 (0.26) 3 (1—21)
J01CA04 Amoxicillin 51 (46) 1.4 (0.23) 3 (1—28)
J01EE01 TMP—SMXf 11 (10) 1.5 (0.35) 4 (1—10)
J01FA01 Erythromycin 6 (5.5) 1.3 (0.39) 2 (1—10)
J01GB04 Kanamycin 3 (2.7) 1.5 (0) 2 (2—3)
J01MA02 Ciprofloxacin 4 (3.6) 0.9 (0.13) 2.5 (2—5)
P01AB01 Metronidazole 4 (3.6) 1.4 (0.25) 2.5 (1—4)
Total courses 119
a Group A = patients upon admission to hospital.
b Group B = patients visiting a public health centre.
c Group C = relatives accompanying patients of group A.
d PDD = prescribed daily doses in grams, mean (standard deviation).
e Median (range) of duration of treatment in days.
f TMP—SMX = trimethoprim—sulfamethoxazole.population varied between 16% and 25%. Hereafter, the
consumption data refer to the 486 individuals who definitely
took antimicrobial drugs.
The overall proportion of antibiotic users did not differ
between SBY and SMG. Large differences were seen between
the groups: 7% for relatives, 19% for patients at the health
center, and 22% for patients on admission to hospital. Four
hundred and seventeen (86%) individuals could specify name
and dosage. This applied to 447 antibiotic courses, with 389
(93%) individuals citing a single antibiotic, 26 individuals two
antibiotics, and two individuals three antibiotics. Approxi-
mately 92% of the antibiotics were dispensed as tablets,
capsules, and syrup for oral use. Injections accounted for
only 2%.
Overall 71% of the courses were either amoxicillin or ampi-
cillin, slightly more often prescribed for children (76% of
prescriptions for children) than adults (69%; p = 0.16)
(Tables 2 and 3). Amoxicillin or ampicillin was consumed by
60% of adults in group A and 78% of group C. All but one of the
treatments for children of groups B and C consisted of amox-
icillin or ampicillin. For adults, 9% of the courses were for
tetracyclines, which were only used once by a child. Tetra-
cycline use did not differ between the groups. Among children
the second most common antibiotic was trimethoprim—sulfa-
methoxazole: 12% of courses against 6% among adults. All
except one course of trimethoprim—sulfamethoxazole had
been taken by children in group A. Chloramphenicol and
thiamphenicol were frequently used: 6% of courses taken by
adults and 12% by children, who all belonged to group A.
The prescribed daily dose for adults (PDD) of most anti-
biotics was in the order of magnitude of the defined daily
dose (DDD).18 PDDs were lower than DDDs for chloramphe-
nicol 1.6 g vs. 3 g and ampicillin 1.4 g vs. 2 g, and higher for
amoxicillin 1.4 g vs. 1 g.
The median duration of most antibiotic treatments was 3
days. Less than 3% of treatments lasted for more than 10
days. The mean duration of self-medication was significantlyGroup Bb (N = 123) Group Cc (N = 64)
Courses
n (%)
PDDd Duratione Courses
n (%)
PDDd Duratione
21 (17) 1.3 (0.4) 3 (1—9) 7 (11) 0.9 (0.4) 3 (1—5)
5 (4.1) 1.1 (0.4) 3 (3—7) 5 (7.8) 1.1 (0.4) 3 (3—5)
- - - - - -
30 (24) 1.4 (0.2) 3 (1—9) 13 (20) 1.6 (0.5) 3 (1—7)
65 (53) 1.4 (0.2) 3 (1—14) 39 (61) 1.4 (0.7) 3 (1—12)
6 (4.9) 1.2 (0.8) 3 (2—4) 2 (3.1) 1.4 (0.7) 2 (2—2)
2 (1.6) 1.5 (0) 5 (3—7) 1 (1.6) 1.5 5
- - - - - -
- - - - - -
1 (0.8) 0.5 3 - - -
130 67
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Table 3 Antibiotic use by children (<18 years) in one month
ATC code Group Aa (N = 87) Group Bb (N = 31) Group Cc (N = 2)
Courses
n (%)
PDDd Duratione Courses
n (%)
PDDd Duratione Courses
n (%)
PDDd Duratione
J01AA07 Tetracycline 1 (1.1) 0.3 2 - - - - - -
J01BA01 Chloramphenicol 8 (9.2) 0.6 (0.28) 3 (1—9) - - - - - -
J01BA02 Thiamphenicol 4 (4.6) 0.9 (0.47) 1 (1—3) - - - - - -
J01CA01 Ampicillin 17 (20) 0.9 (0.45) 3 (1—14) 14 (45) 0.80 (0.50) 4 (2—7) 1 (23) 0.75 4
J01CA04 Amoxicillin 50 (57) 0.7 (0.42) 3 (1—14) 16 (52) 0.82 (0.51) 3 (2—6) 1 (56) 1.9 4
J01EE01 TMP—SMXf 15 (17) 0.6 (0.47) 2 (1—9) 1 (3) 0.72 3 - - -
J01FA01 Erythromycin 1 (1.2) 1 3 - - - - - -
J01MA01 Ofloxacin 1 (1.2) 0.8 1 - - - - - -
P01AB01 Metronidazole 1 (1.5) 0.4 1 - - - - - -
Total courses 98 31 2
a Group A = patients upon admission to hospital.
b Group B = patients visiting a public health centre.
c Group C = relatives accompanying patients of group A.
d PDD = prescribed daily doses in grams, mean (standard deviation).
e Median (range) of duration of treatment in days.
f TMP—SMX = trimethoprim—sulfamethoxazole.
Table 4 Independent determinantsa of antibiotic use
Determinant Antibiotic use OR (95% CI)
Yes (N = 480) n (%) No (N = 2248) n (%) Univariate Multivariate
Area
Surabaya 223 (46) 1156 (51) 0.82 (0.67—1.00) -
Group
A (Patients on admission to hospital) 218 (45) 614 (27) 4.62 (3.46—6.16) 3.74 (2.77—5.04)
B (Patients at primary health center) 192 (40) 724 (32) 3.45 (2.58—4.61) 2.87 (2.13—3.88)
C (Healthy household contacts) 70 (15) 910 (41) Reference group Reference group
Sex
Male 199 (42) 821 (37) 1.23 (1.01—1.51) -
Age
18 years old 324 (68) 1929 (86) 0.34 (0.27—0.43) 0.49 (0.38—0.62)
Geographic provenance
Urban 307 (64) 1464 (65) 0.97 (0.79—1.19) -
Ethnicity
Javanese 469 (98) 2126 (95) 2.45 (1.31—4.57) 2.35 (1.24—4.45)
Employment
None 97 (30) 573 (30) 1.002 (0.78—1.30) -
Health insurance
None 331 (69) 1664 (74) 0.78 (0.63—0.97) 0.75 (0.60—0.94)
Education
None 32 (10) 185 (10) 1.03 (0.70—1.53) -
Income
Low 196 (41) 995 (44) 0.87 (0.71—1.06) -
OR, odds ratio; CI, confidence interval.
a Independent determinants were identified by multivariate analyses applied to variables significantly associated with antibiotic use in
univariate analysis. Six individuals who reported antibiotic use without complaints and 262 individuals who did not know whether the drug they
took was an antibiotic were excluded from the analysis.
Survey of antibiotic use, Indonesia 627lower, i.e., 2.8 (standard deviation (SD) 2.1) days, compared
with courses prescribed by a healthcare provider, 3.7 (SD 2.8)
days ( p = 0.024).
Morbidity
Almost all patients (99%) who used antibiotics reported
health complaints, compared to 62% of the individuals who
did not take antibiotics. The proportion of individuals with
complaints who consumed antibiotics was 36% in group A, 23%
in group B, and 16% in group C. Complaints indicating invol-
vement of a specific organ system were reported by 954
individuals: respiratory tract symptoms (cough and/or flu
and/or fever) 80%, gastrointestinal symptoms (diarrhea with
or without fever) 13%, skin symptoms (itching/skin infec-
tions) 5%, and urinary tract symptoms 2%. One hundred and
two individuals reported fever without other symptoms. The
remainder (817 individuals) had symptoms not indicative of a
specific localization of disease.
Providers
Of the 486 individuals who definitely took an antibiotic, 472
(97%) could indicate the provider: prescribed by doctors in
public hospitals (12%), healthcare center (29%), private
practice (36%), nurses and midwives (6%). Self-medicationTable 5 Independent determinantsa of self-medication with antib
Determinant OTC/SM
Yes (N = 72) n (%) N
Area
Surabaya 48 (67) 1
Group
A (Patients on admission to hospital) 20 (28) 1
B (Patients at primary health center) 33 (46) 1
C (Healthy household contacts) 19 (26)
Sex
Male 34 (47) 1
Age
18 years old 66 (92) 2
Geographic provenance
Urban 59 (82) 2
Ethnicity
Javanese 72 (100) 3
Employment
None 20 (28)
Health insurance
None 57 (77) 2
Education
None 5 (8)
Income
Low 30 (41) 1
OTC/SM, over the counter or self-medication; OR, odds ratio; CI, confid
a Independent determinants were identified by multivariate analyses ap
univariate analysis. Fourteen individuals who used both prescribed andwas reported in 17% of cases (8% obtained from a pharmacy
without prescription, 5% from drugstores, 2% from friends
and relatives, 1% from kiosks, and 1% from other sources).
Determinants
Comparison of non-users with users showed that antibiotic use
was higher among children (<18 years), individuals of Java-
nese ethnicity, and those with health insurance (Table 4). The
analysis was repeated with non-users versus users including
the individuals who had possibly taken an antibiotic. This did
not change the findings significantly. In another analysis, the
demographic and socioeconomic characteristics of 398 indivi-
dualswhousedantibioticsonprescriptionwerecomparedwith
those of 74 individuals with self-medication (Table 5). Being
adult, male, and living in an urban area were the strongest
associated factors. No differences were found in the type of
complaints between individuals on self-medication and those
using antibiotics on prescription. Tetracyclines were the only
antibiotics that were significantly more often self-medicated
than prescribed (OR 4.15, 95% CI 2.05—8.4).
Discussion
This is the first survey on overall antibiotic use in populations
outside hospitals in Indonesia. It shows that antibiotic useiotics
OR (95% CI)
o (N = 394) n (%) Univariate Multivariate
64 (42) 2.81 (1.65—4.76) -
92 (49) 0.28 (0.14—0.56) 0.49 (0.23—1.05)
51 (38) 0.59 (0.31—1.12) 1.17 (0.57—2.37)
51 (13) Reference group Reference group
56 (40) 1.37 (0.82—2.26) 2.34 (1.32—4.15)
48 (63) 6.48 (2.74—15.31) 6.79 (2.69—17.18)
34 (59) 3.10 (1.65—5.85) 4.51 (2.26—8.98)
85 (98) - -
74 (30) 0.98 (0.54—1.76) -
65 (67) 1.85 (1.01—3.39) 2.42 (1.26—4.64)
27 (11) 0.67 (0.25—1.82) -
62 (41) 1.02 (0.61—1.70) -
ence interval.
plied to variables significantly associated with self-medication in the
self-medicated antibiotics were excluded from the analysis.
628 U. Hadi et al.was prevalent in Indonesian patients and their relatives.
Comparedwith the relatives, patients visiting a health center
and patients on admission to hospital had a 2.4-fold and 3.3-
fold higher risk, respectively, of having used an antibiotic in
the month before the interview. The differences are most
likely explained by the fact that relatives were healthy,
patients visiting health centers had minor illnesses, and
patients on admission to hospital were more severely ill.
Symptoms of respiratory tract infections were most fre-
quently reported with gastrointestinal symptoms ranking
second. Older, low cost antibiotics were mostly used, mainly
aminopenicillins. This finding is in line with earlier observa-
tions in Asian countries.19—21
The use of amphenicols, restricted in most countries, was
still surprisingly high in our study. The widespread use of
these antibiotics in the extramural setting, mostly for com-
plaints pointing at respiratory tract or gastrointestinal infec-
tions, raises questions about their appropriateness. Most
respiratory tract infections are considered of viral origin
and therefore antibiotics are not useful. The results of a
randomized controlled trial in West Java demonstrating that
ampicillin plus supportive care offers no benefit over suppor-
tive care alone for treatment of mild respiratory tract infec-
tions in young Indonesian children, support this point.22
Although bacterial pathogens can be found in up to 21% of
acute diarrhea cases admitted to hospital,7 most antibiotics
consumed by our population were not likely to be effective.
Resistance rates of enterotoxigenic Escherichia coli (ETEC)
heat-labile toxin (LT) and heat-stable toxin (ST), the most
frequent bacterial cause of acute diarrhea in children as well
as adults in Indonesia, are 67% LT and 83% ST for ampicillin,
48% LT and 70% ST for trimethoprim—sulfamethoxazole, and
95% LT and 85% ST for tetracycline.7Shigella spp account for
27% of bacterial causes of diarrhea, and Shigella flexneri
demonstrate resistance to ampicillin and tetracycline in 50%
and 83%, respectively.8
As expected, having health complaints was the most
important determinant of antibiotic use. Another indepen-
dent determinant of antibiotic use was being less than 18
years old. Worldwide, the barrier to (over)prescribe antibio-
tics to children is lower than to adults, which may be caused
by a greater fear of a poor outcome. The independent
determinant ‘Javanese ethnicity’ is more difficult to explain;
cultural factors might play a role. Finally, individuals with
health insurance consumed antibiotics more frequently. Free
medical care has been described as a determinant of anti-
biotic use by others; it was associated with the use of more
expensive drugs in the community in rural China.23,24 Inver-
sely, changes in reimbursement have resulted in reducing
overuse.21,25
An important finding for tailoring future interventions is
that authorized healthcare providers prescribed the majority
of the antibiotics that were taken by the study population.
This was also found in Mexico.26 Only a limited amount of use,
17%, consisted of self-medication in our population. This
figure is comparable to 27% self-medicated antibiotics con-
sumed before a medical consultation in Chinese pediatric
respiratory tract infection cases.23 In contrast, a large pro-
portion (66%) of children arriving for outpatient care had
already been self-administering antibiotics in Taiwan.21
Another interesting finding was that prescribed or self-medi-
cated antibiotics did not differ, except tetracycline that wassignificantly more often used without prescription. Self-med-
icating individuals also predominantly used the same afford-
able antibiotics. Copying behavior of prescribers, providers,
and patients is discussed in a review by Radyowijati and
Haak.27 Healthcare professionals also determine the
‘health-seeking behavior’ of the public. Duration of self-
medication courses was shorter than that of courses pre-
scribed by regular healthcare providers. This was also
observed in Mexico, where the duration of treatment was
four days when the drug was prescribed by a physician,
compared to a median of two days when the drug was
self-medicated.26
Our study has some limitations. The data are not applic-
able to the general Indonesian population. This was not a
community-based survey. Data were collected only in a
population visiting healthcare services. Two out of the
three groups involved patients and one included relatives
of patients. However within our study population, the data
on the relatives, mostly adults, probably approximate the
situation of the adult population in the community. The
prevalence of antibiotic use of 7% in this group was com-
parable to the 5% reported from Mexico,26 but higher than
the 3.5% prevalence found in Pakistan.28 However one
should be careful when comparing with other countries.
Indonesia has many islands, and we only studied two areas
in Java (Central and East), the most developed island.
Regional disparities of healthcare and health status exist,
and were accentuated by the recent economic crisis. We
only interviewed individuals at public healthcare institu-
tions. However, the survey showed that these same indivi-
duals also consult private providers. Public providers have
private practice after office hours,13 but might have dif-
ferent prescribing behavior in this setting.13 Finally, these
results should be interpreted with some caution as the
morbidity and antibiotic use were self-reported and there-
fore a subjective and imprecise measure. The one-month
recall period might be rather long for interviewees to recall
specific and reliable information on symptoms and antimi-
crobial drugs. However, this recall period has been used by
others in Indonesia14 and other Asian countries.19,28 Adult
literacy rates are relatively high in Indonesia, 86% and 83%
in Central and East Java, respectively,12 which was con-
firmed by our data and should render the information on
drugs by our interview more reliable than in some other
low-income countries with high illiteracy rates. However,
we cannot rule out that we missed antibiotic use and that
‘possible antibiotic use’ might have been actual use.
In conclusion, knowing that themajority of the complaints
leading to antibiotic use were probably of viral origin and
that many bacteria that cause diarrhea are resistant to
aminopenicillins in Indonesia, a large proportion of antibiotic
consumption was either unnecessary or ineffective. Our
results should urge healthcare officials to promote the pru-
dent use of antibiotics. Healthcare authorities can stimulate
the development of national evidence-based guidelines by
scientific societies and support further research on the use of
antibiotics; individual doctors can change their prescription
behavior by adhering to these guidelines. Primary targets for
improved prescribing are the treatment of respiratory tract
infections and gastroenteritis. Since most of the antibiotics
were prescribed by doctors, any intervention should primar-
ily concentrate on the doctors.
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